SUSQUEHANNA INTERNATIONAL GROUP, LLP - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$6,133,853
-56.2%
118,186
-49.4%
0.00%
-66.7%
Q2 2023$13,994,664
+12.0%
233,400
-7.7%
0.00%0.0%
Q1 2023$12,499,767
+52.0%
252,827
+75.4%
0.00%
+50.0%
Q4 2022$8,225,784
+2.7%
144,135
-15.5%
0.00%0.0%
Q3 2022$8,008,000
+18.9%
170,578
-5.5%
0.00%0.0%
Q2 2022$6,734,000180,5090.00%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$28,523,07325.19%
Velan Capital Investment Management LP 200,000$9,888,0008.43%
RTW INVESTMENTS, LP 5,649,943$279,333,1825.82%
Paradigm Biocapital Advisors LP 1,126,256$55,682,0975.28%
Rock Springs Capital Management LP 3,001,662$148,402,1693.54%
Logos Global Management LP 500,000$24,720,0003.54%
TANG CAPITAL MANAGEMENT LLC 405,600$20,052,8642.99%
GREAT POINT PARTNERS LLC 255,367$12,625,3442.48%
COWEN AND COMPANY, LLC 405,174$20,031,8022.35%
Eschler Asset Management LLP 60,000$2,966,4002.34%
View complete list of IMMUNOCORE HLDGS PLC shareholders